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Inhibition of cholesterol transport in an intestine cell model by pine-
derived phytosterols 
 
Jinsoo Yia, Tine A. Knudsenb, Anne-Louise Nielsenc, Lars Duelunda, Morten 
Christensena, Pablo Hervellaa, David Needhama, Ole G. Mouritsena*  
 
Abstract  
 
We have quantified the inhibition of intestinal cholesterol transport by pine-derived 
phytosterols using an HT29-MTX intestine cell model that   forms a mucus layer 
similar to that in the intestine.  An artificial intestinal fluid consisting of digested fat, 
bile salt, cholesterol, and phytosterols was formulated in order to mimic the 
conditions in the intestine. The apparent permeability coefficient  (Papp) of the 
positive control, i.e., 0.1 mM of cholesterol solubilized in the artificial intestine fluid, 
was found to be 0.33 (± 0.17) x 10-6 cm/s. When 0.1 mM β-sitosterol was solubilized 
alongside, Papp was effectively zero, corresponding to a total inhibition of cholesterol 
transport.  A similar strong inhibition was found when commercial pine-derived 
phytosterols, PinVitaTM FSP DuPont, were co-solubilized with cholesterol in the 
dietary model micelles, leading to Papp = 0.06 (± 0.06) x 10-6 cm/s, i.e., 5.5 times 
lower than the cholesterol positive control. Additionally, the effect of potential oral 
administration formulations generated by the pine-derived phytosterols was also 
characterized. The formulations were produced as a liquid formulation to the 
cholesterol-containing artificial intestine fluid. Six liquid formulations were tested of 
which four displayed a Papp in the range of 0 to 0.09 x 10-6 cm/s. The other two 
formulations did not show any inhibition effect on cholesterol transport and even 
stimulated cholesterol transport. It was furthermore observed that the phytosterols 
were found in the collected intestine cells but not transported to the basolateral 
region in the intestinal cell model system.  
 
Key words: HT29-MTX intestinal cell model, apparent permeability coefficient, 
cholesterol, β-sitosterol, pine-derived phytosterols, sterol transport, PinVitaTMFSP 
DuPont 
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1. Introduction 
 
Cholesterol is a lipid that plays a pivotal role in many biochemical and 
biophysical processes. Cholesterol is the precursor of various steroid hormones, bile 
salts, and vitamin D3, and is essential for maintaining the proper rigidity of the 
plasma membrane (Rozner and Garti, 2006). However, excess amount of cholesterol 
in the blood vessels is the main reason for provoking cardiovascular disease (CVD), 
coronary heart diseases (CHD) and increased mortality rate (Martin et al., 1986; 
Weingartner et al., 2011). Cholesterols are supplied to the body through the food 
(exogenous) or synthesized in liver (endogenous). The exogenous cholesterol is 
delivered to the apical side of the intestines after food digestion by means of bile 
salts and lipases. Continuously, the degraded lipid components of the intestines 
(monoglycerides, fatty acids, and cholesterols) are transformed from hydrophobic 
material into a colloidal structure, such as micelles, with aid of the bile salts (Carey et 
al., 1983). Ashworth and Lawrence showed that the 3-25 nm diameter of 
monoglyceride-oleic acid of digested lipid micelles were optimized to be absorbed 
into enterocytes (Ashworth and Lawrence, 1966). When the micelles enter into the 
enterocytes, cholesterols, monoglycerides, and fatty acids are re-esterified as 
cholesteryl esters, triglycerides, and phospholipids, which are main components of 
secreted particles (chylomicrons), and then transferred to the basolateral region 
(Carey et al., 1983; Chang et al., 2009), as illustrated in Fig. 1. 
 Phytosterols and plant-derived compounds are known for their ability to 
lower cholesterol levels in the blood stream (Brauner et al., 2012; Jones et al., 1997; 
Ostlund, 2004; Ostlund et al., 2002; Raederstorff et al., 2003). Phytosterols are lipids 
with a very similar chemical structure to cholesterol, they are more hydrophobic, 
and humans cannot synthesize them. Therefore, the phytosterols are available orally 
from vegetables, plant oils, plant extracts, or plant origin supplements (Ostlund, 
2007). The mechanism behind inhibition of cholesterol uptake by phytosterols is still 
not well characterized. It was previously reported that the phytosterols can inhibit 
cholesterol uptake through creating bio-unavailable crystals with cholesterol in the 
stomach and intestines (Christiansen et al., 2003; Rozner and Garti, 2006), limiting 
the cholesterol solubility in the dietary micelles, blocking metabolic effects of 
cholesterol in intestinal cells (Brauner et al., 2012; Trautwein et al., 2003). Still, the 
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effect of phytosterols against cholesterol absorption in the serum appears well 
established in practice, and consequently phytosterol supplements are used for 
cholesterol lowering efficacy (Brauner et al., 2012; De Smet et al., 2012). In order to 
optimize such supplementation there is a need for a deeper and quantitative 
understanding of the inhibition mechanism. 
The intestine cell model system is a very useful tool to investigate drug 
absorption, nutrient transport, nanoparticle transport, and sterol transport in vitro 
(Ehrhardt and Kim, 2008; Hilgendorf et al., 2000; Langerholc et al., 2011; Rubas et al., 
1993; Sun and Pang, 2008). Previously, cholesterol transport was tested in an 
intestinal model system using Caco-2 cells (Field et al., 1997; Palmgren et al., 2005; 
Petruzzelli et al., 2009). Caco-2 cells have been widely applied to study drug 
absorption in vitro and to predict drug bioavailability (Rubas et al., 1993; Sun and 
Pang, 2008). In recent work, HT29-MTX cells were preferred over Caco-2 cell model 
for studies of lipophilic molecular transport, since the HT29-MTX cell line forms a 
mucus layer on the surface of the apical region of the cells (Behrens et al., 2001). 
Because this model system is closer to the natural intestine tissue structure as it 
consist of mixed population of absorptive cells and mucus-producing cells (Lesuffleur 
et al., 1990; Lesuffleur et al., 1991). Finally, from the intestine cell model 
measurements, it is possible to calculate the apparent permeability coefficient 
(hereafter, Papp) to be compared with that obtained in the Caco-2 cell model system 
(Rubas et al., 1993). The Papp values of hydrophobic compound transport found when 
using HT29-MTX cells are lower than the values pertaining to Caco-2 cells due to a 
physical barrier of the mucus layer formed by HT29-MTX cells (Behrens et al., 2002). 
Papp is the relevant assessment value of drug delivery and compares to the in vivo 
effect indirectly (Rubas et al., 1993). 
The aim of the present paper is to quantify the transport of cholesterol in the 
intestine cell model using a customized artificial intestinal fluid with lipophilic 
micelles composed of digested fats. Simultaneously, the inhibition of cholesterol 
transport by phytosterols (β-sitosterol and the commercial pine-derived phytosterol) 
was characterized by determination of Papp. In the current study, we have used the 
non-modified sterols in order not to influence the transport by the chemical 
modification. Additionally, the commercial pine-derived phytosterol supplement was 
formulated differently and used to test a potential oral administration. 
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2. Materials and methods 
2.1. HT29- MTX cell culture and trans-epithelial electrical resistance (TEER) 
The HT29-MTX cell-line was originally provided by Dr. Thécla Lesuffleur  
(INSERM UMR S 938, Paris, France). The cell culture medium was high glucose 
DMEM (Gibco®, Thermo Fisher Scientific, Waltham, MA USA) supplemented with 
10% heat-inactivated FBS (Sigma-Aldrich, St. Louis, MO USA), 100 unit/ml of 
Penicillin (Sigma-Aldrich), 100 μg/ml of Streptomicin (Sigma-Aldrich), and 2 mM of 
GlutaMAXTM-I (Gibco®). Cells were grown at 37oC using a 5% CO2 incubator (NuAire 
DHD Autoflow, Plymouth MN, USA). The cells were grown in a Petri dish of 10 cm in 
diameter and in successive subculture until reaching passage 29th. To obtain the cell 
growth curve, 0.89 x 105 cells/cm2 of cells were grown in each wells of a 12-well cell 
culture plate (Nunc® Sigma-Aldrich) with 3 replications. After an EDTA-trypsin 
(Sigma-Aldrich) treatment, the number of cells was counted every two days for the 
growth curve. For the intestine cell model system, the grown cells were transferred 
into 12-well trans-well culture plates (0.4 μm pore polycarbonate membrane insert, 
1.12 cm2 culture area, Corning®, Sigma-Aldrich) and seeded in each well using 1 x 105 
cells/ well (0.89 x 105 cells/cm2). 0.5 ml of medium was added in the donor chamber 
and 1.5 ml of medium in the acceptor chamber (Fig. 1). The cell culture medium was 
replaced every day. The trans-epithelial electric resistance (TEER) of grown HT29-
MTX cells on the filter membrane in the trans-well plates was measured by a 
Voltohmmeter (Milipore, Millicell-ERS, Billerica MA, USA) with chopstick-like 
electrodes. To monitor the variation of TEER, three replicated trans-well plates were 
separately prepared, and the TEER was measured every second day.  
 
2.2. Two-photon excitation confocal laser microscopy 
Cells grown for 15 days on filter membrane were treated with 100 μg/ml of 
Hoechst 33342 (Invitrogen) to stain the nuclei of the HT29-MTX cells. The stained 
cells were observed by two-photon confocal laser microscope (LSM 510 ZEISS, Jena, 
Germany) at 780 nm excitation with a detector of 390-465 nm emission, employing 
an HFT KP650 filter and an NFT 490 reflection mirror. The three-dimensional view 
was reconstructed by ImageJ (National Institutes of Health, Bethesda, MD USA). 
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2.3. Artificial intestinal fluid for cell model system 
An artificial intestine fluid (AIF) was prepared with cholesterol, digested fats 
(monoglycerides and fatty acids), bile salt (sodium taurocholate), and Hanks buffered 
saline with magnesium and chloride, pH 7.5 (HBSS++, Gibco®). Monoglyceride (MG) 
(DuPont, Dimondan® MO 90/D, Aarhus, Denmark) and oleic acid (OA) (Sigma-Aldrich) 
were mixed at a ratio 1:2 at 40oC in a thermomixer (Thermomixer Comfort, 
Eppendorf AG, Hamburg, Germany). 0.1 mM cholesterol (CORDENPHARMA, Liestal, 
Switzerland) as positive control, 0.1 mM cholesterol + 0.1 mM of β-sitosterol (Sigma-
Aldrich) as co-micelles with pure analytical phytosterol, and 0.1 mM cholesterol + 0.1 
mM of β-sitosterol including a commercial Pine-derived phytosterol product 
(hereafter CPP, PinVitaTM FSP, DuPont, which contains 77.6 % β-sitosterol, 11.3% β-
sitostanol, 6.6% Campesterol, 1.2% Campesterol, 0.7% Stigmasterol, and over 3% of 
other sterols) as co-micelles with natural phytosterol extract, were dissolved with 
0.5 mM of MG, 1 mM of OA, 33 mM of sodium taurocholate (Sigma-Aldrich) in 
HBSS++.  The three negative controls were prepared as HBSS++ (Neg.Cont I), HBSS++ 
with 33 mM of sodium taurocholate (Neg. Cont II), and HBSS++ with 33 mM of 
sodium taurocholate and 1:2 molar ratio of MG:OA mixture (Neg. Cont III). In details, 
1 mM of cholesterol, 1 mM of cholesterol + 1 mM of β-sitosterol, and 1 mM of 
cholesterol + 1 mM β-sitosterol in CPP (calculated from 77.6% of β-sitosterol) in each 
of 50.7 μl of the 1:2 molar ratio of MG:OA mixture (hereafter, MG/OA) were 
prepared and then, the each of 2.54 μl of dissolved 1 mM cholesterol, 1 mM 
cholesterol +1 mM β-sitosterol, and 1 mM cholesterol+1 mM CPP in MG/OA was 
added in drop wise in 5 ml of 33 mM sodium taurocholate in HBSS++ and 2.54 μl of 
the only MG/OA was added for the Neg. Cont III. The solutions were separately in 
the glass vials and heating up to 40 oC, stirring overnight on a thermo stirrer (IKA® 
RT10P, London, UK). The fat mecelles were produced in 33 mM sodium taurocholate 
in HBSS++. The CPP was tested in two ways; co-micelle solubilization with cholesterol 
in MG/OA in the process described above as well as mimicking of potential oral 
administration.  
When mimicking the oral administration, the liquid CPP of six different 
formulations followed a pH change to mimic the conditions of acidic stomach and 
neutral intestine. Initially the liquid formulations were stirred overnight, followed by 
a decrease in pH to 2 using HCl. The low pH formulations were stirred for 1 hour. 
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Subsequently the formulations were neutralized to pH 7 using NaOH and finally 
tested in the cell model. The pH change was measured by a pH meter (EUTECH 
instrument pH510, Landsmeer, Netherland) at room temperature. In order to ensure 
precise β-sitosterol concentration in CPP, care was taken to adjust this to identical 
concentrations of 0.1 mM by volume adjustments. The CPP formulations have 
different concentration of β-sitosterol and the used volume was hence recalculated 
each to reach a concentration of 0.1 mM β-sitosterol. The pH-adjusted solutions 
were added drop wise in 5 ml of 0.1 mM of cholesterol-MG/OA micelles and 33 mM 
sodium taurocholate in HBSS++, i.e., the same composition of the positive control.  
The particle size and the zeta-potential were measured by dynamic light 
scattering (DelsaMax pro, Beckman-Coulter Indianapolis, USA). All particles were 
measured at 20oC in triplicates. The cell model system was implemented as follows: 
15 days of cultured cells were prepared in 12-well trans-well plates, 0.5 ml of the 
prepared fluidic samples (Table 1) were added in the donor chambers and 1.5 ml of 
HBSS++ were placed in the acceptor chambers after washing the cultured cells three 
times with HBSS++. Each sample was prepared in three replicas. The treated cells 
were incubated on the shaking incubator at 37oC for 1 hour with mild shaking (70 
rpm) in a shaking incubator (ES-20 BIOSAN, Riga, Latvia). After incubation, 0.5 ml of 
solution was collected from both the donor chambers and the acceptor chambers. 
Additionally, the HT29-MTX cells were washed with HBSS++ three times and 
collected by cell scrapers (24 cm, TPP® Trasadingen, Switzerland) with 0.5 ml HBSS++ 
for HPLC sterol analysis in the intestinal cells. 
 
2.4. Atomic force microscopy 
Atomic force microscopy (AFM) was used to detect and visualize input 
micelles originating from the donor chamber of the positive control, and following 
the incubation with the reconstructed AIF, in order to monitor the transported 
micelles from the acceptor chamber. Since the cholesterol-MG/OA micelles showed 
a negative zeta-potential (Table 1), the silicon wafers, used to adhere the micelles, 
were modified by 3-aminopropyl triethoxysilane (APTES) (Sigma-Aldrich) to achieve a 
positively charged substrate that could attract the negatively charged micelles. The 
~1 cm2 cut silicon wafers (Si (100), Plano GmbH, Wetzlar, Germany) were cleaned 
with a boiling solution of 4:1:1 H2O (Ultrapure water from a integral 5 unit, Millipore 
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A/S, Billerica, MA USA), NH4OH (28-30%, Sigma-Aldrich), and H2O2 (34.5-36.5%, 
Sigma-Aldrich) for 10 minutes and subsequently rinsed with ultrapure water, 
followed by cleaning in a plasma cleaner for 10 minutes (Harrick Plasma, Ithaca NY, 
USA). The clean wafers were hydrolyzed with 5% APTES in 95% ethanol (Kemetyl, 
Køge, Denmark) at pH 4.5-5.5 for 2 hours on a rack platform. The excess amount of 
APTES solution was removed by washing with 95% ethanol 3 times. The 
organosilane-modified substrates were cured at 100oC overnight and stored in 
vacuum. The micelle solutions were mixed in 1:1 ratio with a 2% osmium tetroxide 
(Sigma-Aldrich) solution, spread on the organosilane-modified silicon wafers, and 
incubated for 1 hour. The wafers were then washed with ultrapure water and dried 
under nitrogen gas. The prepared silicon wafers with micelles were visualized by 
AFM (Nano Wizard I, JPK Instruments AG, Berlin, Germany) in intermittent contact 
mode (tapping mode). Cantilevers had a tip radius lower than ~7 nm and a force 
constant of ~40 N/m (PPP-NCHR, Nanosensor, Neuchatel, Switzerland) operated at 
~330 kHz. Visualization and subsequent image analysis were accomplished using 
SPIPTM (Scanning Probe Image Process, Image Metrology A/S, Hørsholm, Denmark). 
 
2.5. Sterol quantification by high performance liquid chromatography (HPLC) 
The total amounts of sterols, including free and esterified sterol, were 
quantified from the 0.5 ml solution of the donor chambers and acceptor chambers 
as well as the scraped cells in 0.5 ml of HBSS++ buffer. The samples were hydrolyzed 
by mixing 0.5mL of sample with 0.5mL of 5% KOH in methanol followed by shaking at 
60oC for 20 min (Thermomixer Comfort, Eppendorf AG, Hamburg, Germany). Sterols 
were extracted from the reaction mixture by the use of supported-liquid extraction 
in a Biotage ISOLUTE SLE+ tube (Biotage, Uppsala, Sweden) with a sample capacity of 
1ml. Samples were eluted with 2 times of 1.5ml of hexane. The combined extracts 
were evaporated under at stream of nitrogen at 60˚C in a block heater (Stuart 
SBH200D/3 equipped with a SBHCONC/1 sample concentrator, Bibby Scientific, 
Stone, UK). Samples were then dissolved in 150 μl of metanol/acetonitrile,30/70, 
and filtered with 0.2 μm PTFE syringe filters (VWR, Søborg, Denmark). The sterols 
were then quantified by HPLC on a Shimadzu Prominence HPLC consisting of a 
DGU20-A5 in-line degasser, LC-20AD pumps, SIL20A-HT autosampler, CTO 10 Column 
oven and a SPD-20A UV detector (Shimadzu, Kyoto, Japan). Samples were separated 
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on a Supleco Ascentis® Express RP-Amide 15 cm x 2.1 mm, 2.7 µm column (Sigma-
Aldrich) with a mobile phase of acetonitrile/methanol, 90/10, flowing at a rate of 0.3 
ml/min. The sterols were detected in the UV-detector at 210 nm and quantified by 
standards of the pure compounds, cholesterol and β-sitosterol. 
 
2.6. Calculation of sterol quantification 
The concentration of cholesterol and β-sitosterol in the donor chamber, 
intestine cells, and acceptor chamber was measured by HPLC. The amount of 
transported cholesterol was compared with negative controls and the apparent 
permeability coefficient (Papp) was calculated by the following equation (Hilgendorf 
et al., 2000).  
 
𝑃𝑃𝑎𝑎𝑎𝑎𝑎𝑎 =  d𝑄𝑄 𝑉𝑉𝑎𝑎d𝑡𝑡 𝐴𝐴 𝐶𝐶𝑜𝑜 
 
where dQ/dt is the steady-state flux of sterols across the HT29-MTX cell layer 
calculated after 1 hour incubation (mM/s), Va is the volume of acceptor chamber, A 
is the surface area of absorbing membrane in the trans-well plate (1.12 cm2), and C0 
is the initial concentration of cholesterol in donor chamber (0.1 mM) (Hilgendorf et 
al., 2000). In order to calculate the cell permeability coefficient (Pc) for cell 
absorption of sterols, we calculated the flux defined as the mass of substrate 
through a given cross-sectional area in a given time. Pc can be calculated from the 
flux and the initial concentration of substrate as follows (Steffansen et al., 2010). 
 
𝐽𝐽 = 𝑚𝑚
𝐴𝐴𝑡𝑡
  
𝐽𝐽 = 𝑃𝑃𝑐𝑐𝐶𝐶0   ↔   𝑃𝑃𝑐𝑐 = 𝐽𝐽𝐶𝐶0 
 
where J is the flux, m is the mass of transported sterols determined by the HPLC 
values from collected HT29-MTX cells, A (cm2) is the cross-sectional area (1.12 cm2), t 
is incubation time (s), and C0 is the initial concentration in donor chamber (μg/ml). 
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 3. Results 
3.1. HT29-MTX cell growth and trans-epithelial electrical resistance 
HT 29-MTX cells were seeded at a concentration of 0.8 x 105 cells/cm2 and 
reached confluence in 10 days, with a concentration of 4 x 105 cells/cm2  (Fig. 2A). 
The cells were then grown continuously to an almost three times higher number of 
cells, compared with the confluence, in 15 days and showed stationary state from 
then on. After reaching the stationary state, the HT29-MTX cells obtained a tissue-
like property and we observed a fluctuation in the growth curve and a high value of 
standard error after 15 days of culture. The trans-epithelial electrical resistance 
(TEER) showed a concomitant increase in resistance that accompanied the growth of 
cells to confluence and did not reach its maximum value until at 15 days in culture 
but decreased after then (Fig. 2B). Similarly to the growth curve, the TEER curve was 
fluctuating after 15 days of culture (Fig. 2B). Thus, 15 days in culture was the optimal 
culture time for trans-epithelial experiments. 
 
3.2. Multilayered structure formation of HT29-MTX cells 
As shown in Fig. 3, the HT29-MTX cells that were grown for 15 days on the 
trans-well plate displayed a folded shape and were multilayered when viewed under 
the confocal laser microscope. The nuclei of the cells were stained with Hoechst 
33342 and can be seen in the z-axis stacked images obtained by two-photon 
confocal laser microscopy. The XZ axis and YZ axis images showed a clear 
multilayered structure (Fig. 3A). The three-dimensional view of the reconstructed 
image by ImageJ showed the folded shape of the intestine tissue-like structure (Fig. 
3B). 
 
3.3. Physico-chemical properties of artificial intestine fluid  
Artificial intestine fluid (AIF) was defined as the input solution in the donor 
chamber for cholesterol transport.  Three negative controls were used in the study 
and prepared to assess the intestinal cell model reaction to the buffer, bile salt, and 
monoglyceride/oleic acid without cholesterol. Table 1 shows the composition of the 
tested AIF and the physico-chemical properties of micelles of fats (monoglycerides, 
oleic acids, cholesterols, and phytosterols). Using dynamic light scattering, no 
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particles were detected in the buffer control (negative control I). From the bile salt 
control (negative control II) to the sterol-included AIF had very small particles, from 
2.3 nm to 3.1 nm in diameter. In addition, the zeta-potential of the particles was 
negative, -24 mV and -14 mV in negative control II and negative control III, 
respectively. When sterols were added, the zeta-potential dropped from -44.1 mV to 
-51.2 mV. The particle sizes for the potential oral administration test of the 
cholesterol-micelles and the liquid formulations of the commercial pine-derived 
phytosterol varied from 23.4 nm to 590.6 nm in diameter and the zeta-potential of 
the formulation-included particles in AIFs displayed negative values in the range of -
45 mV to -55 mV (see Table in Ref [1]) 
 
3.4. Trans-Epithelial Electrical Resistance (TEER) of HT29-MTX upon incubation with 
artificial intestine fluid 
As shown in Table 2, incubation of the cell culture with all of AIFs increased 
the trans-epithelial electrical resistance (TEER) of HT29-MTX within 1 hour by 
anywhere between 12 – 65 Ω∙cm2. Especially, cholesterol-containing AIF (positive 
control) showed about 20% higher TEER value than negative controls (Table 2). A 
similar behavior was also observed for the TEER of the formulations for the potential 
oral administration of the commercial pine-derived phytosterol (CPP), which all 
samples contained cholesterol (also listed in Table 2). Those cholesterol-containing 
AIF plus formulations caused an increase the TEER value of 21 Ω∙cm2 in average, with 
the exception of formulation D with an increase of 71 Ω∙cm2 that is considered as an 
outlier. Interestingly, the micelle formation of cholesterol together with β-sitosterol 
and CPP showed the higher TEER increase, with increased values of 37 and 39 Ω∙cm2 
respectively, compared with the cholesterol in different formulations for the 
potential oral administration test (except the already mentioned outlier formulation 
D). 
 
3.5. Size measurement of AIF in the donor chamber 
The positive control of micelles in the artificial intestine fluids (AIF) were 
analyzed by atomic force microcopy (AFM) and a dynamic light scattering (DLS). The 
micelles in the positive control of AIF (see Table 1) was successfully attached to the 
APTES modified silicon wafer with OsO4 fat staining and observed by AFM (Fig. 4A). 
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The largest size population of nanoparticles was less than 10 nm and the mean size 
of micelles was 14.9 ± 0.57 nm (Mean ± SE, N=388) that were over evaluated as 
described in discussion. Fig. 4B showed the particle size distribution from the 
dynamic light scattering (DLS), the mean value being 2.3 ± 0.4 nm (Mean ± 
polydispersity of DLS, N=3, Table 1, positive control). There was a difference 
between AFM observations and DLS measurements but the largest population of the 
nanoparticles were less than 10 nm in diameter in both measurements. 
 
3.6. Sterol transport analysis and apparent permeability coefficient 
Cholesterol transport through the intestine cell model system was evaluated 
by measuring the cholesterol concentration in the AIF and in the acceptor chambers 
by HPLC. The amount of transported cholesterol and β-sitosterol was then quantified. 
The positive control added in the donor chamber (0.5 ml of 0.1 mM of cholesterol) 
showed the highest cholesterol transport into the acceptor chamber with a value of 
0.055 ± 0.028 μg (Mean ± SE, N=3, Fig. 5). In the first negative control (buffer, Neg. 
Cont. I), cholesterol was not detected in the acceptor chamber. The other negative 
control of bile salt (Neg. Cont. II) showed transport cholesterol in the accept 
chamber as 0.008 ± 0.008 μg (Mean ± SE, N=3). In the third negative control of bile 
salt/monoglyceride/oleic acid in donor chamber (Neg. Cont. III), the cholesterol was 
detected in the acceptor chambers, as 0.01 ± 0.01 μg (Mean ± SE, N=3). No 
cholesterol was detected in the acceptor chamber in the sample with the 0.1 mM of 
cholesterol and 0.1 mM of β-sitosterol in the donor chamber. In the presence of CPP 
with cholesterol in the donor chamber, the cholesterol was detected as 0.011 ± 
0.011 μg (Mean ± SE, N=3), about the same cholesterol transport value as of two 
negative controls (Neg. Cont. II and Neg. Cont. III) as shown in Fig. 5. 
Based on the initial cholesterol concentration in the donor chamber from 
positive control, the apparent permeability coefficient (Papp) was calculated. The 
cholesterol Papp of the positive control was 0.33 ± 0.17 x 10-6 cm/s (Mean ± SE, N=3). 
The Papp of the β-sitosterol + cholesterol co-micelle test was 0 and the Papp of the CPP 
+ cholesterol co-micelle test was calculated as 0.06 ± 0.06 x 10-6 cm/s (Mean ± SE, 
N=3) (Table.3). The cholesterol transport inhibition was shown by the values of the 
Papp of cholesterol in Fig. 6. In the potential oral administration test, most of 
formulations (A, B, C, and F) showed an effect on cholesterol transport with values of 
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Papp from 0 to 0.09 x 10-6 cm/s. However, formulation D and E increased the 
cholesterol transport more than the positive control.  
 
3.7. Cholesterol and β-sitosterol absorption in the intestine cells 
β-sitosterol was not detected in any of the analyzed acceptor chambers, even 
in the acceptor chambers of formulation D and E that showed higher cholesterol 
transport than positive control.  However, β-sitosterol was detected in the intestinal 
cells, which were collected after three times washing with HBSS++. In order to 
investigate the absorption correlation between cholesterol and β-sitosterol, the cell 
permeability coefficient (Pc) of cholesterol and β-sitosterol was calculated (Table 3). 
Pc expresses the sterol absorption from the donor chamber (apical region) into the 
intestinal cells. In the cholesterol positive control (cholesterol in MG/OA micelles 
with bile salt), cholesterol Pc was found to be 17.64 ± 0.70 x 10-6 cm/s (Mean ± SE, 
N=3). In the presence of β-sitosterol, the analyzed cholesterol Pc increased to 24.55 ± 
7.64 (x 10-6 cm/s). By comparison of cholesterol Pc and β-sitosterol Pc, the presence 
of β-sitosterol did not seem to have an effect on the cholesterol absorption in the 
intestinal cells. In the presence of β-sitosterol only, the flux of cholesterol to the cells 
was increased 1.34 times but in the presence of commercial pine-derived 
phytosterol (CPP), the cholesterol flux was decreased 2.2 times compared with the 
positive control (Table. 3). In the potential oral administration formulation test, the 
cholesterol flux into the intestine cells was lower than 23% in average. More β-
sitosterol (1.3-13.5 times) was detected in the intestinal cells in the potential oral 
administration test of CPP in comparison with the co-micelle test of β-sitosterol (β-
sitosterol Pc was 0.54 ± 0.04 x 10-6 cm/s, Mean ± SE, N=3) and CPP (β-sitosterol Pc 
was 0.94 ± 0.19 x 10-6 cm/s, Mean ± SE, N=3). However, the amount of β-sitosterol 
absorbed in the intestine cells was not relevant to the cholesterol permeability to 
acceptor chamber in any case (Table 3). 
 
4. Discussion 
The HT29-MTX cell growth profile was different from the typical sigmoidal 
behavior of animal cell line cultures. The cells were continuously growing up to three 
fold (15.5 x 105 cells/cm2) over its confluence in 15 days of culture (Fig. 2A). After 15 
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days of the culture, the cell growth curve was fluctuating and the TEER value 
dropped hugely (150 Ω∙cm2) from 425 Ω∙cm2 in 15 days of culture to 275 Ω∙cm2 in 16 
days of culture. The TEER value was increased again to 400 Ω∙cm2 in 17 days of 
culture. This phenomenon indicated a possibility to produce an unstable intestinal 
model system during continuous cell growing after 15 days of culture. Therefore, the 
HT29-MTX cells were used after 15 days of culture in this study. 
The artificial intestine fluids used in this work were designed and prepared to 
mimic the absorbable lipid micelles that are produced by in vivo fat metabolism by 
various lipases (Carey et al., 1983) and the digested fats such as monoglycerides and 
fatty acids were used accounting for in the developed in vitro system. Therefore, the 
artificial intestine fluid needs to be composed of the hydrolyzed fats that form 
absorbable micelles to enter enterocytes (Fig. 1). Previously, an in vivo rat intestine 
fat absorption study showed that the micelles composed of monoglyceride, oleic 
acids, and 40 mM of bile salt were successfully attached the cell membrane of 
intestine microvilli brush border throughout the mucus layer (Ashworth and 
Lawrence, 1966). Ashworth and Lawrence did not observe the transported nano-
sized micelles in the cytoplasm but observed membrane thickening as well as found 
visible intravesicular lipid droplets in the cytoplasm; the digested fat micelles are 
absorbed into cells but the mechanism is not clear. Accordingly, in the present study, 
the components of artificial intestinal fluid (AIF) were mixed and combined to form 
micelles with particle sizes below 20 nm in diameter (Table 1). The digested fats 
used in the present work were 0.5 mM of monoglyceride and 1 mM of oleic acid 
(MG/OA) due to solubility of 0.1 mM of cholesterol with 33 mM of sodium 
taurocholate that is related to lipid digestion and lipophilic micelle formation. In 
details, the bile salt was used 6-13 times higher concentration compared with 
previous studies of intestine cell model system (Field et al., 1997; Palmgren et al., 
2005; Petruzzelli et al., 2009).  The amount corresponds to the physiological 
condition in the Duodenum and small intestine of the human body because the 3-4 g 
of bile salt was secreted to Duodenum 8 times a day (around 24-32g per day) and 
reabsorbed in colonic enterocytes (Heaton, 1969; Hofmann, 1999), and the average 
volume of human Duodenum, the place of lipid digestion, was reported to be 275.5 
ml from 105 people, aged from 13-93 years old (Suman, 2013). Based on these data, 
bile salt concentration is over 70 mM in the Duodenum and then is diluted by the 
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volume of the small intestine. The relatively high concentration of bile salt would 
keep the micelles of absorbable size, 3 nm-25 nm (Ashworth and Lawrence, 1966). 
The used amount of bile salt in the present work was chosen in a concentration that 
forms the size of absorbable micelle formation into enterocytes (see Figure in Ref 
[2]) 
 In the present study we have shown that the sizes of the most of micelles 
are less than 20 nm as determined by AFM and DLS. The seemingly larger sizes 
measured in AFM compared to DLS is likely due to particle flattening upon adhesion, 
and individual particle widening due to the size of the cantilever tip (~7 nm). 
Moreover the resolution of the AFM images is around ~5 nm2. Therefore the particle 
size measurement by AFM has a slight tendency to overestimate the size 
distribution. The largest distribution however is in the size range expected from 
comparing with DLS (<10 nm). The average size of nanoparticles was consistently 
less than 20 nm, which is the absorbable size relevant for enterocytes (Fig. 4). 
We have used KOH/methanol saponification to isolate sterols (cholesterols 
and phytosterols) from collected samples as well as to hydrolyze cholesteryl ester 
that could be synthesized from cholesterol with acylcoenzyme A:cholesterol 
acyltransferase (ACAT) in the intestinal cells (Chang et al., 2009; Han et al., 2014). In 
order to discern the cholesterol transport through intestinal cells regardless of bile 
salt and fat emulsion effect, we have used three negative controls; only HBSS++ 
buffer, HBSS ++ plus bile salt and HBSS++, and bile salt plus MG/OA. A small amount 
of cholesterol transport was detected in the bile salt and MG/OA control that could 
come from a natural cholesterol metabolism stimulated by bile salt and MG/OA. The 
positive control showed a five-fold higher cholesterol transport than negative 
controls (Fig. 5). 
Subsequently, the commercial pine-derived phytosterols (CPP) inhibited 
cholesterol transport in the intestine model system. The used CPP contained 77.6 % 
β-sitosterol, 11.3% β-sitostanol, 6.6% Campesterol, 1.2% Campesterol, 0.7% 
Stigmasterol, and over 3% of other sterols. β-sitosterol is well-known cholesterol 
transport inhibitor and the major composition of the CPP. Therefore, we used β-
sitosterol as the analytical control and standard to use amount of CPP in the test. 
The apparent permeability of cholesterol (cholesterol Papp) showed the perfect 
cholesterol transport inhibition by β-sitosterol (Fig. 6). In the presence of CPP, the 
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cholesterol was detected in only one acceptor chamber out of 3 replicates likewise in 
the second and third negative controls. Therefore, the abnormal value of standard 
error (SE) of cholesterol Papp of CPP (0.06 ± 0.06 x 10-6 cm/s (Mean ± SE, N=3)) was 
calculated because the transported cholesterol was not detected in two acceptor 
chambers out of three replicates likewise in the two negative controls (Table 3). The 
data indicated that the CPP blocked the cholesterol transport effectively with 
cholesterol or similar value of negative controls without added cholesterol. The 
cholesterol transport in the two negative controls seems to be natural fat 
metabolism of intestine cells, stimulated by bile salt or added digested fats 
(monoglyceride and oleic acid). Since CPP is for a commercial supplement to 
administrate orally, the six different liquid formulations were tested by the 
mimicking condition of the acidic stomach and the neutral intestine. Four 
formulations showed clear effects of cholesterol transport inhibition but two 
formulations even stimulated cholesterol transport (Table 3). The stimulated 
formulations would not be recommended for oral administration based on the test.  
 Another interesting result of the present work is the finding of cholesterol 
transport inhibition by the commercial pine-derived phytosterols (CPP). The CPP 
includes around 77.6% of β-sitosterol that was considered as a competitor for 
intestinal cell absorption in the intestinal lumen (Christiansen et al., 2003; Trautwein 
et al., 2003), but β-sitosterol cell permeability (Pc) was not significantly influencing 
cholesterol absorption in the cells (Table 3). β-sitosterol was not detected in the any 
of acceptor chambers indicating that β-sitosterol is absorbed in the cell but not 
transported to the basolateral region. Therefore, the site of cholesterol transport 
inhibition of phytosterols could be in the intestine cells as reported in previous 
studies (Brauner et al., 2012; Rozner and Garti, 2006). Considering our finding of an 
increase of the trans-epithelial electric resistance (TEER) by β-sitosterol and CPP by 
37 and 39 Ω∙cm2, respectively, the present study supports earlier suggestions that the 
cholesterol transport inhibition is related to stabilization of the cell membrane by 
phytosterols (Rozner and Garti, 2006). 
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5. Conclusion 
Cholesterol transport was successfully inhibited by β-sitosterol and the 
commercial pine-derived phytosterols (CPP) in an HT29-MTX intestinal cell model. 
The CPP supplement was effective to inhibit cholesterol transport in co-micelle 
formation of an artificial intestine fluid as well as in the potential oral administration 
test. There are 6 different classified formulations of CPP corresponding to different 
ways of administration. Four formulations out of six tested formulations displayed a 
clear effect of cholesterol transport inhibition, while two formulations did not inhibit 
cholesterol transport. Moreover, cholesterol transport was increased in two 
formulations (Fig. 6). Therefore, formulation of the CPP seems to be a critical factor 
for oral administration with the purpose of cholesterol uptake inhibition.  
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Fig. 1. The schemes of the intestinal cell model system for cholesterol transport. 
Triglycerides, cholesterol ester, and phospholipids are digested by bile salts and 
lipases in the intestine lumen, and the digested monoglycerides, fatty acids, and 
cholesterol-containing micelles enter into intestine cells and are transported to the 
basolateral region in the form of chylomicrons. Fat digestion and absorbable micelle 
formation in the intestine lumen (left). The digested fat including cholesterol is 
transported from the apical region to the basolateral region by forming chylomicrons 
(upper right). The experimental set-up for the intestinal cell model system (lower 
right). The set-up of the intestinal cell model system for cholesterol transport is also 
shown (lower right). BA: bile salt, MG: monoglyceride, FA: fatty acid, TG: triglyceride, 
PS: phospholipid, C: cholesterol, CE: cholesteryl ester.  
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Fig. 2. Growth curves and development of cell layer trans-epithelial electric 
resistance (TEER).  (A) Cell growth curve of HT29-MTX cells for 20 days in a 12-well 
cell culture.  (B) The variation of TEER of HT29-MTX cells on a filter membrane in the 
12 trans-well plates by days of culture. The upper line (black) is the TEER variation of 
HT29-MTX cells by days of culture; the lower line (red) is the control of TEER. All 
values were Mean ± SE (N=3). 
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Fig. 3. Two-dimensional and three-dimensional images from a Z-stack from two-
photon confocal laser microscopy of HT29-MTX cell nuclei after 15 days of culture 
stained by Hoechst 33342. (A) Multilayered structure from two-dimensional (XY-axis, 
XZ-axis, and YZ axis) images of the cultured cells. (B) Three-dimensional view of Z-
stack image (XYZ-axis); the cells were folded likewise intestine tissue. 
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Sample description Composition of AIF Size in Dia. (nm) z-potential (mV) 
Negative control I 0.01 M HBSS++  -  - 
    
Negative control II 
33 mM sodium 
taurocholate 2.3 ± 0.1  - 24.0 ± 1.7 
 
0.01 M HBSS++ 
  
    Negative control III 0.5 mM MG/ 1 mM OA 2.6 ± 0.3  -13.7 ± 3.9 
 
33 mM sodium 
taurocholate 
  
 
0.01 M HBSS++ 
  
    Positive control 0.1 mM cholesterol 2.3 ± 0.4  -51.2 ± 7.4 
Cholesterol-micelles 0.5 mM MG/ 1 mM OA 
  
 
33 mM sodium 
taurocholate 
  
 
0.01 M HBSS++ 
  
    Cholesterol+β-sitosterol 0.1 mM β-sitosterol 3.0 ± 0.4  -46.4 ± 2.2 
micelles 0.1 mM cholesterol 
  
 
0.5 mM MG/ 1 mM OA 
  
 
33 mM sodium 
taurocholate 
  
 
0.01 M HBSS++ 
  
    Cholesterol+CPP* micelles CPP (0.1 mM β-sitosterol) 3.1 ± 0.4  -44.1 ± 6.7 
 
0.1 mM cholesterol 
  
 
0.5 mM MG/ 1 mM OA 
  
 
33 mM sodium 
taurocholate 
    0.01 M HBSS++     
CPP*: commercial pine-derived phytosterol supplement, 77.6% of β-sitosterol included. 
All values were Mean ± PD (polydispersity of DSL), N=3 
 
 
 
 
Table 1. Physico-chemical properties of artificial intestine fluid (AIF) and AIF 
compositions of each donor chamber for the intestine cell model.  
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Sample description TEER (Ω∙cm2) before incubation   TEER (Ω∙cm2) after incubation 
Negative control I 252 ± 13   260 ± 20 
    Negative control II 281 ± 6 
 
298 ± 17 
    Negative control III 291 ± 3 
 
311 ± 23 
    Positive control 
283 ± 8  348 ± 35 (only cholesterol micelles) 
 
    Cholesterol + β-sitosterol 
Co-micelles 279 ± 13 
 
316 ± 16 
    Cholesterol + CPP 
Co-micelles 276 ± 15 
 
315 ± 28 
    CPP formulations for the 
potential oral 
administration test 
 
  
 
    Cholesterol micelles + 
290 ± 3  303 ± 4 Formulation A 
 
    Cholesterol micelles + 
275 ± 9  303 ± 37 Formulation B 
 
    Cholesterol micelles + 
291 ± 15  312 ± 8 Formulation C 
 
    Cholesterol micelles + 
265 ± 8  336 ± 3 Formulation D 
 
    Cholesterol micelles + 
301 ± 29  328 ± 15 Formulation E 
 
    Cholesterol micelles + 
293 ± 8  314 ± 32 Formulation F   
 
 
Table 2. Trans-epithelial electrical resistance (TEER) before and after 1 hour 
incubation with artificial intestine fluid in a trans-well set-up of HT29-MTX cells.  
All values were Mean ± SE (N=3).  
CPP: commercial pine-derived phytosterol supplement 
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Fig. 4. Measurements of micelle size by AFM and DLS.  (A) AFM observation of the 
positive control of 388 micelles in the donor chamber (the image in a box in the 
graph) and the size distribution of nanoparticles from AFM. Size bar: 500 nm (B) The 
size distribution from DLS of the micelles. 
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Fig. 5. Cholesterol transport in the presence of phytosterols in a HT29-MTX intestinal 
cell model system with co-micelle formation of cholesterol and phytosterols,. 
Compared with negative controls, cholesterol transport is inhibited by β-sitosterol 
and CPP.  
Neg. Cont.: negative control, CPP: commercial pine-derived phytosterol supplement.  
All values were Mean ± SE (N=3). 
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Sample description 
Cholesterol cell Flux 
X10-6 (μg/cm2s) 
Cholesterol, Pc  
X10-6 (cm/s) 
β-sitosterol cell flux  
X10-6 (μg/cm2s) 
β-sitosterol, Pc 
X10-6 (cm/s) 
Cholesterol, Papp  
X10-6 (cm/s) 
β-sitosterol Papp 
X10-6 (cm/s) 
  Co-micelles in intestinal cell model test 
Only cholesterol 728.92 ± 28,84 17.64 ± 0.70  -  - 0.33±0.17  - 
Cholesterol + β-sito 1014.45 ± 315.66 24.55 ± 7.64 38.94 ± 7.95 0.94 ± 0.19 0 0 
Cholesterol + CPP 329.04 ± 48.58 7.96 ± 1.18 22.28 ± 1.79 0.54 ± 0.04 0.06±0.06 0 
  Potential oral administration test in intestinal cell model 
Cholesterol + CPP_A 500.27 ± 25.49 12.11 ± 0.62 215.70 ± 26.50 5.2 ± 0.64 0.05±0.05 0 
Cholesterol + CPP_B 617.39 ± 259.47 14.94 ± 6.28 302.05 ± 16.76 7.28 ± 0.40 0.05±0.05 0 
Cholesterol + CPP_C 516. 00 ± 63.97 12.49 ± 1.55 52.20 ± 6.96 1.26 ± 0.17 0.09±0.05 0 
Cholesterol + CPP_D 540.25 ± 226.20 13.07 ± 5.47 60.33 ± 11.30 1.45 ± 0.27 10.74±5.23 0 
Cholesterol + CPP_E 724.60 ± 86.11 17.54 ± 2.08 65.76 ± 25.98 1.59 ± 0.63 0.89±0.66 0 
Cholesterol + CPP_F 444.12 ± 28.75 10.75 ± 0.70 754.83 ± 80.00 5.51 ± 0.58 0 0 
Pc: Cell permeability coefficient, hereby sterol absorption from apical region to intestine cells 
Papp: Apparent permeability coefficient, hereby sterol absorption form apical region to basolateral region 
CPP: commercial pine-derived phytosterol supplement 
All values were Mean ± SE (N=3). 
 
 
 
Table 3. The flux to the intestine cells, cell permeability coefficient, and apparent 
permeability coefficient of cholesterol and β-sitosterol in the intestine cell model.  
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Fig. 6. The cholesterol apparent permeability of the co-micelle test (CHOL+β-sito. 
and CHOL+ CPP) and the mimic of oral administration test (six CPP formulations, A to 
E).  Compared to the positive control (only CHOL in the graph), the two co-micelle 
testers as well as the formulation A, B, C, and F show a clear inhibition of cholesterol 
transport, whereas formulation D and E show increased cholesterol transport.  
All values were Mean ± SE (N=3).  
CPP: commercial pine-derived phytosterol supplement 
 
 
 
 
 
 
 
 
 
 
